AI assisted COVID-19 diagnostic and prognostic tool could improve resource allocation and patient outcomes.
Seven of Europe’s leading cancer centres have today published a report detailing how they have organized their healthcare systems at an unprecedented scale and pace to make their operations ‘pandemic proof’ during the COVID-19 pandemic.
Dr Karen Pinilla is a clinical research fellow at the Cancer Research UK Cambridge Centre. She worked as a clinician in the breast unit at Addenbrooke’s Hospital before starting her fellowship in October 2019. She is now based in both Addenbrooke’s Hospital and the Cancer Research UK Cambridge Institute.
Scientists have created one of the most detailed maps of breast cancer ever achieved, revealing how genetic changes shape the physical tumour landscape, according to research funded published in Nature Cancer.
A new type of scan that involves magnetising molecules allows doctors to see in real-time which regions of a breast tumour are active, according to research at the University of Cambridge and published in Proceedings of the National Academy of Sciences.
A major international study of the genetics of breast cancer has identified more than 350 DNA ‘errors’ that increase an individual’s risk of developing the disease. The scientists involved say these errors may influence as many as 190 genes.
Cambridge scientists are set to benefit from a major cash injection from Cancer Research UK and partners to develop radical new strategies and technologies to detect cancer at its earliest stage.
Whole genome sequencing of tumour cells could help predict the prognosis of a patient’s cancer and offer clues to identify the most effective treatment, suggests an international study published today in Nature Medicine.
Dr Kate Dry is Information Specialist in Professor Steve Jackson’s Lab at the Gurdon Institute. Here, she tells us about unexpected career paths, working in science while raising a family, and being a member of a world-leading cancer research lab.
/
9
